Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
The extent to which Alzheimer neuropathology, particularly the accumulation of misfolded beta-amyloid, contributes to cognitive decline and dementia in Parkinson's disease (PD) is unresolved. Here, we used Florbetaben PET imaging to test for any association between cerebral amyloid deposition a...
Main Authors: | Tracy R. Melzer, Megan R. Stark, Ross J. Keenan, Daniel J. Myall, Michael R. MacAskill, Toni L. Pitcher, Leslie Livingston, Sophie Grenfell, Kyla-Louise Horne, Bob N. Young, Maddie J. Pascoe, Mustafa M. Almuqbel, Jian Wang, Steven H. Marsh, David H. Miller, John C. Dalrymple-Alford, Tim J. Anderson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.00391/full |
Similar Items
-
Tracking Parkinson's Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease.
by: Tracy R Melzer, et al.
Published: (2015-01-01) -
Reduced striatal volumes in Parkinson’s disease: a magnetic resonance imaging study
by: Pitcher Toni L, et al.
Published: (2012-08-01) -
Changes of plasma cGP/IGF‐1 molar ratio with age is associated with cognitive status of Parkinson disease
by: Dawei Fan, et al.
Published: (2020-01-01) -
Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI)
by: Ann J. Jones, et al.
Published: (2017-06-01) -
Positive Association of Ascorbate and Inverse Association of Urate with Cognitive Function in People with Parkinson’s Disease
by: Emma S. Spencer, et al.
Published: (2020-09-01)